Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Pilot Open Label, Sequential Group, Investigator Blinded Study of Magnetic Resonance Spectroscopy (31P-MRS) to Assess the Effects of CNM-Au8 for the Bioenergetic Improvement of Impaired Neuronal Redox State in Parkinson's Disease

Next Previous
Search
Trial Profile

A Phase 2, Pilot Open Label, Sequential Group, Investigator Blinded Study of Magnetic Resonance Spectroscopy (31P-MRS) to Assess the Effects of CNM-Au8 for the Bioenergetic Improvement of Impaired Neuronal Redox State in Parkinson's Disease

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 20 May 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CNM Au8 (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacodynamics
  • Acronyms REPAIR-PD
  • Sponsors Clene Nanomedicine

    • Most Recent Events

    • 14 Dec 2023 According to a Clene Nanomedicine media release, results from this trial were published in the Journal of Nanobiotechnology, a Springer Nature journal.
    • 25 May 2023 According to a Clene Nanomedicine media release, announced that Clene has received a grant from the National Multiple Sclerosis Society (NMSS) via the organization's Fast Forward Program and this 1 year grant will fund Cohort 2 of REPAIR-MS.
    • 18 Nov 2021 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top